Frélii, Inc. (FRLI) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, Frélii, Inc. (FRLI) es una empresa del sector Technology valorada en 0. La acción obtiene una puntuación de 51/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 17 mar 2026Perfil Tecnológico y Posición Competitiva de Frélii, Inc. (FRLI)
Frélii, Inc. provides personalized, subscription-based nutrition and wellness programs, leveraging genetic data and lifestyle factors to tailor health plans. Operating within the application software sector, the company offers a platform for health assessments, nutritional guidance, and related products, targeting consumers seeking customized wellness solutions.
Tesis de Inversión
Frélii, Inc. presents a unique investment opportunity within the personalized nutrition and wellness space. The company's focus on leveraging genetic data and lifestyle factors to create customized health plans offers a differentiated approach in a growing market. With a gross margin of 22.5%, there's potential for profitability as the company scales its subscription-based model. Key value drivers include expanding its user base through targeted marketing and partnerships, increasing subscription revenue, and introducing new product offerings such as advanced diagnostic kits and personalized supplements. However, potential investors should be aware of the risks associated with the company's OTC listing, including limited liquidity and disclosure. Furthermore, the company's negative profit margin of -15439.4% indicates significant challenges in achieving profitability. The company's high beta of 3.42 suggests high volatility. Success hinges on effective execution of its growth strategies and navigating the competitive landscape.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Frélii, Inc. operates in the personalized nutrition and wellness market, offering customized health plans based on genetic data and lifestyle factors.
- The company's platform, frelii.com, provides health assessments, nutrition plans, lab diagnostic kits, and nutritional supplements.
- Frélii, Inc. was rebranded from Vican Resources, Inc. in March 2018, signaling a strategic shift towards personalized wellness.
- The company's gross margin stands at 22.5%, indicating potential for profitability with increased scale and operational efficiency.
- Frélii, Inc. has a market capitalization of $0.00B, highlighting its early-stage growth potential and associated risks.
Competidores y Pares
Fortalezas
- Personalized nutrition plans based on genetic data.
- Subscription-based revenue model.
- Online platform for program delivery and product sales.
- Offers lab diagnostic kits and compounding pharmacy products.
Debilidades
- Limited market capitalization ($0.00B).
- Negative profit margin (-15439.4%).
- OTC listing with limited liquidity and disclosure.
- Small number of employees (10).
Catalizadores
- Upcoming: Potential partnerships with healthcare providers or fitness centers could expand market reach.
- Upcoming: Launch of a mobile app to enhance user engagement and data collection.
- Ongoing: Expansion of product offerings, such as advanced diagnostic kits and personalized supplements.
- Ongoing: Increasing consumer awareness of personalized nutrition and wellness.
- Ongoing: Leveraging AI and machine learning to improve the accuracy of personalized nutrition plans.
Riesgos
- Potential: Limited liquidity due to OTC Other listing may hinder trading activity.
- Potential: Negative profit margin (-15439.4%) raises concerns about financial sustainability.
- Ongoing: Competition from larger nutrition and supplement companies could erode market share.
- Potential: Changing regulations in the health and wellness industry may impact business operations.
- Potential: Data privacy and security breaches could damage reputation and erode customer trust.
Oportunidades de crecimiento
- Expansion of Product Offerings: Frélii can expand its product line to include more advanced and specialized diagnostic kits. The market for genetic testing and personalized diagnostics is growing rapidly, with a projected market size of $13.8 billion by 2027. By offering a wider range of diagnostic tools, Frélii can attract new customers and increase revenue per user. This initiative can be implemented within the next 12-18 months, requiring investment in research and development and partnerships with diagnostic labs.
- Strategic Partnerships: Collaborating with healthcare providers, fitness centers, and corporate wellness programs can significantly expand Frélii's reach and customer base. The corporate wellness market is a multi-billion dollar industry, with companies increasingly investing in employee health programs. By partnering with these organizations, Frélii can offer its personalized nutrition plans as part of a comprehensive wellness package. These partnerships can be established within the next 6-12 months, requiring a dedicated sales and marketing effort.
- International Market Expansion: Frélii can explore opportunities to expand its services to international markets, particularly in regions with a growing interest in personalized health and wellness. The global wellness market is expanding rapidly, with significant growth potential in Asia-Pacific and Europe. Adapting its platform and services to meet the specific needs and regulations of different countries can open up new revenue streams. This expansion can be phased in over the next 2-3 years, starting with pilot programs in select markets.
- Development of a Mobile App: Creating a user-friendly mobile app can enhance customer engagement and provide a more convenient way for users to access their personalized nutrition plans and track their progress. Mobile health apps are becoming increasingly popular, with millions of users worldwide. An app can also enable Frélii to collect more data on user behavior and preferences, further improving the personalization of its services. The app can be developed and launched within the next 9-12 months, requiring investment in software development and user interface design.
- Leveraging AI and Machine Learning: Implementing AI and machine learning technologies can enhance the accuracy and effectiveness of Frélii's personalized nutrition plans. AI can be used to analyze large datasets of genetic and lifestyle information to identify patterns and predict individual responses to different dietary interventions. This can lead to more precise and effective recommendations, improving customer satisfaction and retention. AI integration can be implemented in phases over the next 12-24 months, requiring investment in data science expertise and AI infrastructure.
Oportunidades
- Expansion of product offerings (e.g., advanced diagnostic kits).
- Strategic partnerships with healthcare providers and fitness centers.
- International market expansion.
- Development of a mobile app.
Amenazas
- Competition from larger nutrition and supplement companies.
- Changing regulations in the health and wellness industry.
- Potential data privacy and security breaches.
- Economic downturn affecting consumer spending on wellness products.
Ventajas competitivas
- Proprietary algorithms for personalized nutrition plan creation.
- Access to genetic data and personalized health information.
- Subscription-based revenue model providing recurring income.
- Established online platform (frelii.com) for program delivery and product sales.
Acerca de FRLI
Frélii, Inc., formerly known as Vican Resources, Inc. until its rebranding in March 2018, operates in the technology sector, specifically within the application software industry. The company is headquartered in Lehi, Utah, and focuses on delivering personalized nutrition and wellness programs through its frelii.com web platform. Frélii's core offering revolves around creating customized health assessments and nutrition plans, taking into account a range of factors including genetic data, individual physiology, environmental influences, and lifestyle choices. These plans are designed to provide users with tailored guidance on diet, exercise, and overall well-being. In addition to its personalized plans, Frélii also provides a suite of related products and services. These include lab diagnostic kits that allow users to gather relevant health data, compounding pharmacy products tailored to individual needs, and a range of nutritional and vitamin supplements designed to support the personalized nutrition plans. The company's business model is centered around subscription-based access to its platform and the sale of these related products. Frélii's competitive positioning is centered around its ability to offer a highly personalized approach to nutrition and wellness, differentiating itself from more generic wellness programs and supplement providers. The company aims to leverage technology and data to provide a more effective and tailored experience for its users.
Qué hacen
- Provide personalized nutrition and wellness programs.
- Offer health assessments based on genetic data and lifestyle factors.
- Create customized nutrition plans tailored to individual needs.
- Provide access to lab diagnostic kits for health data collection.
- Offer compounding pharmacy products.
- Sell nutritional and vitamin supplements.
- Operate an online platform (frelii.com) for program delivery and product sales.
Modelo de Negocio
- Subscription-based access to personalized nutrition and wellness programs.
- Revenue from the sale of lab diagnostic kits.
- Sales of compounding pharmacy products.
- Sales of nutritional and vitamin supplements.
Contexto de la Industria
Frélii, Inc. operates within the rapidly expanding personalized nutrition and wellness market. This market is driven by increasing consumer awareness of the link between diet, lifestyle, and health outcomes. The global wellness market is estimated to be worth trillions of dollars, with personalized nutrition representing a significant growth segment. Competitors range from large nutrition and supplement companies to smaller, specialized firms offering genetic testing and personalized health plans. Frélii's success depends on its ability to differentiate itself through its technology platform, data-driven approach, and personalized customer experience. The company faces competition from companies like ANVV (Anavex Life Sciences Corp.), CGLO (Cogilo Technologies Corp.), EDTA (Edita Food Industries S.A.E.), GEMSF (GEMS Science Fund I, Inc.), and GOLQ (Gold Lion Holding Inc.).
Clientes Clave
- Individuals seeking personalized nutrition and wellness solutions.
- Health-conscious consumers interested in genetic-based health plans.
- Customers looking for customized vitamin and supplement regimens.
- Users of the frelii.com web platform.
Finanzas
Gráfico e información
Precio de la acción de Frélii, Inc. (FRLI): Price data unavailable
Últimas noticias
-
Stocks That Hit 52-Week Lows On Thursday
· 10 oct 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· 9 oct 2019
-
Stocks That Hit 52-Week Lows On Tuesday
· 8 oct 2019
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para FRLI.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para FRLI.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de FRLI en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Ian Geran Jenkins
CEO
Ian Geran Jenkins serves as the CEO of Frélii, Inc. His background includes experience in managing small teams and guiding companies through periods of transition, as evidenced by his leadership at Frélii, which employs 10 individuals. While specific details regarding his prior roles and educational background are not available, his current position indicates a focus on strategic direction and operational oversight within the personalized nutrition and wellness sector.
Historial: As CEO of Frélii, Ian Geran Jenkins has overseen the company's focus on personalized nutrition and wellness programs. Specific milestones and achievements under his leadership are not detailed in the provided information. His tenure is marked by the company's efforts to establish a presence in the competitive market of personalized health solutions.
Información del mercado OTC de FRLI
The OTC Other tier represents the lowest tier of the OTC market, indicating that Frélii, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited operating history, are undergoing financial distress, or may not be current in their reporting obligations. Investing in companies on the OTC Other tier carries significant risks due to the potential for fraud, lack of transparency, and limited liquidity compared to companies listed on major exchanges like the NYSE or NASDAQ. These stocks are often referred to as 'penny stocks'.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited liquidity due to OTC Other listing.
- Lack of transparency and disclosure.
- Potential for fraud and manipulation.
- High price volatility.
- Uncertain financial viability.
- Verify the company's financial statements and reporting status.
- Research the background and experience of the management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's cash flow and ability to fund operations.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Company has a registered business address in Lehi, Utah.
- Company has been in operation since at least 2018 (rebranding from Vican Resources).
- Company has a functional website (frelii.com).
- Company offers a specific product/service (personalized nutrition plans).
- CEO is identified (Ian Geran Jenkins).
Acciones de Frélii, Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar FRLI?
Frélii, Inc. (FRLI) actualmente tiene una puntuación IA de 51/100, indicando puntuación moderada. Fortaleza clave: Personalized nutrition plans based on genetic data.. Riesgo principal a monitorear: Potential: Limited liquidity due to OTC Other listing may hinder trading activity.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de FRLI?
FRLI actualmente puntúa 51/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de FRLI?
Los precios de FRLI se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre FRLI?
La cobertura de analistas para FRLI incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en FRLI?
Las categorías de riesgo para FRLI incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Limited liquidity due to OTC Other listing may hinder trading activity.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de FRLI?
La relación P/E para FRLI compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está FRLI sobrevalorada o infravalorada?
Determinar si Frélii, Inc. (FRLI) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de FRLI?
Frélii, Inc. (FRLI) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Limited financial information available due to OTC Other listing.
- Lack of analyst coverage.